Treatment with glycosaminoglycan-degrading enzymes followed by paper chromatography showed that keratoconus cells, as normal control cells, produced hyaluronic acid and various sulfated glycosaminoglycans. The production of cell layer-related heparan sulfate was markedly reduced in keratoconus cultures. Because heparan sulfate has been shown to be associated with cell surfaces, the decreased heparan sulfate content could reflect changes at this location.
INTRODUCTION
Keratoconus is a disease that gradually thins and distorts the central cornea and usually leads to visual Portions of this work were presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Fla., 2 May 1978.
Receivedfor publication 25 September 1978 and itl revised form 13 November 1978. impairment. Histological and structural changes (1) (2) (3) (4) in the cornea include degeneration of basal epithelial cells, fragmentation of the basement membrane, fibrillation of Bowman's membrane, reduction of the stromal lamellae and their partial replacement by an irregularly arranged connective tissue. The pathogenesis is unknown.
Relatively little biochemical information is available concerning this disease process. A preliminary report (5) has shown that the total amount of glycosaminoglycans (expressed as percentage of hexosamine per dry weight tissue) was 1.4% both in normal human and keratoconus corneas. No significant differences were observed in elution patterns from. an epichlorohydrin triethanolamine column. A subsequent study (6) described a slight increase in the glucosamine:galactosamine ratio from corneas with keratoconus and suggested that the keratan sulfate content was increased, whereas the chondroitin sulfate fraction was decreased. A reduction in the total collagen content (7) and an abnormality in the collagen cross-linking (8) have also been reported. Except for this last study, none of the changes were of sufficient degree to provide assurance that direct measurement of the corneal tissue was a fruitful approach to study this disease.
The use of tissue cultures of skin fibroblasts for investigation of the systemic mucopolysaccharidoses has produced significant advances in the understanding of these conditions (9) . Similar methods with corneal cell cultures have been employed in the study of one corneal disease, macular corneal dystrophy. There was a suggestion of glycosaminoglycan changes by histochemistry (10) but no demonstrable chemical abnormalities (11) .
We have previously characterized the glycosaminoglycans produced by cultures of stromal cells from normal human corneas (12) . With that as background, we undertook this study to investigate the synthesis of glycosaminoglycans by cultures ofcorneal stromal cells from patients with keratoconus. In contrast to the reported absence of glycosaminoglycan changes from macular dystrophic corneal cells, we have observed significant differences in heparan sulfate production from ctrltutred keratoconus corneal cells when compared to normal controls.
METHODS
Cell cultures. Normal human corneas were obtained from the New England Eye Bank, Boston, Mass. Corneal buttons from three patients with keratoconus (a 24-yr-old male with keratoconus for 10 yr; a 44-yr-old male with keratoconus for 15 yr; and a 48-yr-old female with keratoconus for 4 yr) were placed into a McCarey-Kaufman (13) medium immediately after penetrating keratoplasty and sent to our laboratory. All three had bilateral disease suggesting an underlying metabolic defect.
The middle portion of the stromal layer was obtained from corneas as described (14) . This entailed stripping off Descemet's membrane with the attached endothelium and then removing the superficial epithelial stromal layer. The pure explant was cultured as described (15, 16) Sulfated glycosaminoglycans produced by normal and keratoconus stromal cultures were characterized by sequential treatment with chondroitinase AC and chondroitinase ABC (Miles Laboratories Inc., Miles Research Products Elkhart, Ind.) as described (16) . Chondroitinase AC only degrades hyaluronic acid, chondroitin 4-sulfate, and chondroitin 6-sulfate. Chondroitinase ABC degrades these plus dermatan sulfate. Neither enzyme has activity on heparan sulfate, heparin, or keratan sulfate. Carrier standard chondroitin 4-sulfate (Miles Laboratories Inc.) was added in each enzyme incubation to confirm the enzyme activities. After enzyme digestions, each reaction mixture was chromatographed on a column (1 x 20 cm) of Sephadex G-50 with 0.1 M LiCl solution, and radioactivity was determined for each fraction. Degradation products of the carrier standard were located by the carbazole assay (18) . The amount of labeled material appearing in the included fractions from the column represented the degraded glycosaminoglycan products; the amount appearing in the excluded fractions represented the intact glycosaminoglycans resistant to the specific enzyme (16) .
For some samples, the intact glycosaminoglycans recovered after chondroitinase ABC digestion were further treated with crude heparinase prepared from Flavobacterium heparinum as described (16) . This enzyme can degrade all types ofglycosaminoglycans except keratan sulfate.
Disaccharide products of chondroitinase ABC digestion were identified as described (19) by chromatography on Whatman No. 1 paper (Whatman, Inc., Clifton, N. J.) together with disaccharide standards AIDi-4S, ADi-6S, ADi-OS, and unsaturated hyalobiuronic acid.' Chromatograms were developed for 18 h in butan-1-ol:acetic acid:1.0 M ammonium hydroxide (2:3:1, by volume). After chromatography, the carrier disaccharides were visualized with UV light and the chromatograms were then cut into 1-cm strips which were then assayed for radioactivity. The hyaluronic acid content was determined from the amount of [3H]disaccharides co-chromatographing with unsaturated hyalobiuronic acid.
RESULTS
Keratoconus cells (Fig. LA) and normal control cells (Fig. 1B) looked similar under phase-contrast microscopy, displaying the long, thin, spindle-shaped morphological characteristics of fibroblasts. The growth rate and pattern of keratoconus and normal control cells in culture were similar, although it was our impression that keratoconus cells could be subcultured only 10-15 times, whereas normal control cells could be maintained for a longer period (20- 30 subcultures) . This, however, was not examined rigorously. The cell densities and the cell protein contents of cultures are shown in Table I . These represented duplicate flasks that were pooled before assay. There were no apparent differences in cell number or protein content between normal and keratoconus cells.
The production of sulfated glycosaminoglycans by Tables III and IV depict the amounts of the various sulfated glycosaminoglycans isolated from the medium and the cell layer fractions of normal and keratoconus cell cultures. In agreement with our previous report (12) , no significant differences were observed by variations in age of donors and(or) number of subcultures. Chondroitin 6-sulfate always made up the largest portion of the sulfated glycosaminoglycans. Chondroitin 4-sulfate and dermatan sulfate were present in smaller amounts; chondroitinase ABC-resistant material accounting for the remainder. We have previously shown (12, 16) that in normal corneal stromal cell cultures, no heparin is produced and keratan sulfate is present only in minimal amounts. Therefore, the chondroitinase ABC-resistant material is essentially heparan sulfate. Likewise, in keratoconus cells, the chondroitinase ABC-resistant material was degraded by crude heparinase indicating that this represented heparan sulfate and not keratan sulfate.
The relative amounts of the various sulfated glycosaminoglycans in the medium fraction of normal and less heparan sulfate in the cell layer than do normal control cells. Heparan sulfate has been shown to be associated with cell surfaces (20) (21) (22) suggesting that the lower production by keratoconus cells may reflect some changes at the cell surface. It is possible that the decreased glycosaminoglycan content in the cell layer of keratoconus cultures may be an expression of the abnormal matrix imposed by the decreased production of heparan sulfate. It is also possible that other materials such as collagen or structural glycoproteins in the cell layer are not retaining the glycosaminoglycans in the keratoconus cells. We have examined the collagen synthesized by keratoconus cultures and demonstrated that keratoconus cells and normal control cells synthesize similar amounts of collagen and both contain type I collagen and A, B chains. However, the relative amount of A, B chains synthesized was noted to be significantly increased in keratoconus cultures.2 It is known that in cornea, glycosaminoglycans interact closely with collagen. The abnormal collagen synthesis by keratoconus cells could possibly be coupled with variations in the metabolism of glycosaminoglycans. Alternatively, this may involve modifications in the secretion mechanism which result in the releasing of most of the glycosaminoglycans into the growth medium by keratoconus cells. At present it is not clear what is really involved in the disease, partly because of the limitations in relating observations in the corneal cultures to the pathology of keratoconus in vivo. It has been shown (12, 16, 23 ) that corneal cultures produce very little keratan sulfate. Therefore, the pattern of sulfated glycosaminoglycan synthesized is considerably different from that seen in corneal tissues. However, it is still of interest that keratoconus is a disease which shows a modification of the distribution and type of glycosaminoglycans produced in culture.
